Search results
- 1.8500Add to watchlist-0.0300 (-1.60%)At close: Fri. May 10, 2024 4:00 PM EDT · Delayed Quote (USD) · Market closed
- Open1.8400High1.8958Low1.7900
- Mkt Cap15.93MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close1.880052 Wk. Low1.020052 Wk. High20.2000
Related stocks
4 days ago · Get the latest information on iBio, Inc. (IBIO), a biotechnology company that develops precision antibody immunotherapies using AI. See stock performance, financials, news, analysis, and more.
May 3, 2024 · A high-level overview of iBio, Inc. (IBIO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
- Tonix Pharmaceuticals Holding Corp.
- Biotechnology
- 103
- 15.29M
Apr 26, 2024 · Stock analysis for iBio Inc (IBIO:NYSEAmerican) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
- 26
3 days ago · View iBio, Inc IBIO investment & stock information. Get the latest iBio, Inc IBIO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
People also ask
What does IBio Inc (IBio) do?
What will IBio Inc stock price rise this year?
Where is IBio IBio headquartered?
Who owns IBio stock?
Apr 30, 2024 · See the latest iBio Inc stock price (IBIO:XASE), related news, valuation, dividends and more to help you make your investing decisions.
5 days ago · About iBio Stock (NYSEMKT:IBIO) iBio, Inc., a biotechnology company, engages in the development of precision antibodies in the United States. It offers IBIO-100, a preclinical anti-fibrotic program for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis; and EngageTx platform, which provides an optimized CD3 T-cell engager ...
3 days ago · Company Description. iBio, Inc., a biotechnology company, engages in the development of precision antibodies in the United States. It offers IBIO-100, a preclinical anti-fibrotic program for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis; and EngageTx platform, which provides an optimized CD3 T-cell engager antibody panel.